Thyroid Cancer in the Pediatric Population.

Genes (Basel) · 2019 · PMC6771006 · PMID 31540418

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Advanced RAI-refractory DTC in adults has also shown promising results in a recent phase II trial of vandetanib (hazard ratio 0.63) though preliminary results of a phase 3 trial merely showed a trend favoring vandetanib and were not statistically significant [ 116 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.